HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matched unrelated bone marrow transplantation without splenectomy for a child with Gaucher disease caused by homozygosity of the L444P mutation, who also suffered from schizencephaly.

Abstract
Splenectomy followed by bone marrow transplantation (BMT) has been applied successfully in the treatment of neuronopathic Gaucher disease (GD). GD in combination with schizencephaly has not previously been reported. We describe a girl who presented with hemiparesis and oculomotor apraxia since infancy, and thereafter developed progressive anemia, thrombocytopenia, hepatosplenomegaly, psychomotor retardation, and skeletal abnormalities. GD caused by homozygosity of the L444P mutation was diagnosed, in combination with schizencephaly. The child received enzyme replacement therapy for 3 years, followed by successful matched unrelated BMT without splenectomy. The strategy of BMT without splenectomy after a period of enzyme replacement may be feasible in neuronopathic GD.
AuthorsRong-Long Chen, Jia-Woei Hou, Pau-Yuan Chang, Fuu-Jen Tsai, Pen-Jung Wang
JournalJournal of pediatric hematology/oncology (J Pediatr Hematol Oncol) Vol. 29 Issue 1 Pg. 57-9 (Jan 2007) ISSN: 1077-4114 [Print] United States
PMID17230068 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Glucosylceramidase
Topics
  • Anemia (complications, genetics, therapy)
  • Apraxias (complications, genetics, therapy)
  • Bone Marrow Transplantation
  • Brain Diseases (complications, genetics, therapy)
  • Child, Preschool
  • Female
  • Gaucher Disease (complications, genetics, therapy)
  • Glucosylceramidase (genetics)
  • Humans
  • Musculoskeletal Abnormalities (complications, genetics, therapy)
  • Mutation, Missense
  • Paresis (complications, genetics, therapy)
  • Splenectomy
  • Transplantation, Homologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: